These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9497460)

  • 1. Early detection of visual field progression in glaucoma: a comparison of PROGRESSOR and STATPAC 2.
    Viswanathan AC; Fitzke FW; Hitchings RA
    Br J Ophthalmol; 1997 Dec; 81(12):1037-42. PubMed ID: 9497460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of visual field progression in glaucoma.
    Fitzke FW; Hitchings RA; Poinoosawmy D; McNaught AI; Crabb DP
    Br J Ophthalmol; 1996 Jan; 80(1):40-8. PubMed ID: 8664231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining progressive visual field loss in serial Humphrey visual fields.
    Birch MK; Wishart PK; O'Donnell NP
    Ophthalmology; 1995 Aug; 102(8):1227-34; discussion 1234-5. PubMed ID: 9097752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual field progression: comparison of Humphrey Statpac2 and pointwise linear regression analysis.
    McNaught AI; Crabb DP; Fitzke FW; Hitchings RA
    Graefes Arch Clin Exp Ophthalmol; 1996 Jul; 234(7):411-8. PubMed ID: 8817283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of visual field progression in patients with normal pressure glaucoma between eyes with and without visual field loss that threatens fixation.
    Membrey WL; Poinoosawmy DP; Bunce C; Fitzke FW; Hitchings RA
    Br J Ophthalmol; 2000 Oct; 84(10):1154-8. PubMed ID: 11004102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual Field Progression in Patients with Primary Angle-Closure Glaucoma Using Pointwise Linear Regression Analysis.
    Verma S; Nongpiur ME; Atalay E; Wei X; Husain R; Goh D; Perera SA; Aung T
    Ophthalmology; 2017 Jul; 124(7):1065-1071. PubMed ID: 28372858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interobserver agreement on visual field progression in glaucoma: a comparison of methods.
    Viswanathan AC; Crabb DP; McNaught AI; Westcott MC; Kamal D; Garway-Heath DF; Fitzke FW; Hitchings RA
    Br J Ophthalmol; 2003 Jun; 87(6):726-30. PubMed ID: 12770970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global and pointwise rates of decay in glaucoma eyes deteriorating according to pointwise event analysis.
    Nassiri N; Moghimi S; Coleman AL; Law SK; Caprioli J; Nouri-Mahdavi K
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1208-13. PubMed ID: 23329667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statpac 2 glaucoma change probability.
    Morgan RK; Feuer WJ; Anderson DR
    Arch Ophthalmol; 1991 Dec; 109(12):1690-2. PubMed ID: 1841577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refinement of pointwise linear regression criteria for determining glaucoma progression.
    Kummet CM; Zamba KD; Doyle CK; Johnson CA; Wall M
    Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6234-41. PubMed ID: 23908183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency doubling technology perimetry for detection of visual field progression in glaucoma: a pointwise linear regression analysis.
    Liu S; Yu M; Weinreb RN; Lai G; Lam DS; Leung CK
    Invest Ophthalmol Vis Sci; 2014 May; 55(5):2862-9. PubMed ID: 24595388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parafoveal scotoma progression in glaucoma: humphrey 10-2 versus 24-2 visual field analysis.
    Park SC; Kung Y; Su D; Simonson JL; Furlanetto RL; Liebmann JM; Ritch R
    Ophthalmology; 2013 Aug; 120(8):1546-50. PubMed ID: 23697959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual field progression in glaucoma: estimating the overall significance of deterioration with permutation analyses of pointwise linear regression (PoPLR).
    O'Leary N; Chauhan BC; Artes PH
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6776-84. PubMed ID: 22952123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of methods to predict visual field progression in glaucoma.
    Nouri-Mahdavi K; Hoffman D; Ralli M; Caprioli J
    Arch Ophthalmol; 2007 Sep; 125(9):1176-81. PubMed ID: 17846355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of the statpac visual field index.
    Artes PH; O'Leary N; Hutchison DM; Heckler L; Sharpe GP; Nicolela MT; Chauhan BC
    Invest Ophthalmol Vis Sci; 2011 Jun; 52(7):4030-8. PubMed ID: 21467169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of PROGRESSOR and Glaucoma Progression Analysis 2 to Detect Visual Field Progression in Treated Glaucoma Patients.
    De Moraes CG; Ghobraiel SR; Ritch R; Liebmann JM
    Asia Pac J Ophthalmol (Phila); 2012; 1(3):135-9. PubMed ID: 26107328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glaucoma surgery with or without adjunctive antiproliferatives in normal tension glaucoma: 2 Visual field progression.
    Membrey WL; Bunce C; Poinoosawmy DP; Fitzke FW; Hitchings RA
    Br J Ophthalmol; 2001 Jun; 85(6):696-701. PubMed ID: 11371491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Genetic Variant in TGFBR3-CDC7 Is Associated with Visual Field Progression in Primary Open-Angle Glaucoma Patients from Singapore.
    Trikha S; Saffari E; Nongpiur M; Baskaran M; Ho H; Li Z; Tan PY; Allen J; Khor CC; Perera SA; Cheng CY; Aung T; Vithana E
    Ophthalmology; 2015 Dec; 122(12):2416-22. PubMed ID: 26383992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of visual field testing frequency on detection of glaucoma progression with trend analyses.
    Nouri-Mahdavi K; Zarei R; Caprioli J
    Arch Ophthalmol; 2011 Dec; 129(12):1521-7. PubMed ID: 21825177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on risk factors for progression of visual field damage in normal-tension glaucoma].
    Sekine M; Araie M; Suzuki Y; Koseki N
    Nippon Ganka Gakkai Zasshi; 1994 Apr; 98(4):369-73. PubMed ID: 8165969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.